TIDMIPEL
RNS Number : 1126H
Impellam Group plc
30 July 2019
INTERIM RESULTS - UNAUDITED
Impellam Group plc ("Impellam") - London AIM: IPEL; 30 July
2019
Impellam announces its unaudited interim results for the 26
weeks ended 5 July 2019
Revenue and Gross Profit Resilience Continues
Like-for-like(8)
H1 2019(1) H1 2018(1,2) Actual Inc/(Dec) Inc/(Dec)
Revenue (GBP millions) GBP1,135.0 GBP1,107.7 2.5% 1.4%
Gross Profit (GBP millions) GBP135.5 GBP133.3 1.7% 0.1%
Adjusted EBITDA (3)
(GBP millions) GBP25.1 GBP22.1 13.6% 6.0%
Adjusted EBITDA conversion
(4) 18.5% 16.6% 1.9 ppts
Adjusted operating profit
(5) GBP15.9 GBP17.9 (11.2)% (20.2)%
Adjusted operating profit
conversion (6) 11.7% 13.4% (1.7) ppts
Operating profit (GBP millions) GBP9.4 GBP15.3 (38.6)% (45.3)%
Continuing Adjusted Basic
EPS (7) 19.2p 25.3p (24.1)%
Continuing Basic EPS 8.5p 20.9p (59.3)%
Financial results presentation
In 2019 we have adopted IFRS 15 - Revenue from Contracts with
Customers and IFRS16 - Leases. We are required to restate the 2018
comparative results for the IFRS 15 impact (GBP23.9m increase in
revenue, but no impact on gross profit, adjusted EBITDA or
operating profit). For IFRS 16 we have applied the modified
retrospective approach and have therefore not restated the 2018
comparative results for the new standard's material impact.
IFRS 16 affects adjusted EBITDA, operating profit and net debt
and therefore the year-on-year results as reported are not shown on
a comparable basis.
The de-merger of Carlisle Support Services in 2019 has been
treated as a discontinued operation and the 2018 results have been
restated accordingly.
Towards the end of 2018 the Group changed its estimate of the
useful economic life over which it carries brand values. This has
led to an amortisation charge in H1 2019 of GBP3.2m (H1 2018 had no
such charge).
Following these regulatory changes the Group is adopting
'Adjusted Operating Profit' as its Alternative Performance Measure
(APM) for earnings, as this is stated after charging the costs
re-characterised under IFRS 16. As with Adjusted EBITDA previously,
it continues to exclude the amortisation of acquired intangibles
(brand value and customer relationships).
The table below bridges H1 2018 to H1 2019 on a comparable basis
at actual exchange rates.
Discontinued IFRS IFRS Brand
Reported Ops 15 Restated Comparable 16 Value Reported
H1 2018 H1 2018 H1 2018 H1 2018 H1 2019 H1 2019 H1 2019 H1 2019
Revenue 1,109.6 (25.8) 23.9 1,107.7 1,135.0 0.0 0.0 1,135.0
Gross Profit 135.5 (2.2) 0.0 133.3 135.5 0.0 0.0 135.5
Adjusted EBITDA(3) 22.2 (0.1) 0.0 22.1 20.1 5.0 0.0 25.1
Adjusted Operating
Profit(5) 18.0 (0.1) 0.0 17.9 15.5 0.4 0.0 15.9
Operating Profit 15.4 (0.1) 0.0 15.3 12.2 0.4 (3.2) 9.4
Net Debt 79.1 0.0 0.0 79.1 75.0 24.9 0.0 99.9
--------- -----------
(1) IFRS 15 - Revenue from Contracts with Customers was adopted
in 2019, 2018 financial statements were restated (see note 4). IFRS
16 - Leases was adopted in 2019, 2018 financial statements are not
restated (see note 10).
(2) 2018 financial statements restated for discontinued
operations (see note 3).
(3) Before separately disclosed items (see note 5) and
share-based payment (see note 2).
(4) Calculated as Adjusted EBITDA / Gross Profit.
(5) Operating profit before amortisation of acquired intangible
assets, separately disclosed items (see note 5) and share-based
payment (see note 2).
(6) Calculated as Adjusted operating profit / Gross Profit.
(7) Continuing Basic EPS before separately disclosed items (see
note 5), share-based payment (see note 2) and amortisation of
acquired intangible assets (see note 8).
(8) % change measured at constant exchange rates.
Key operational highlights
-- The Group has reviewed its segmental management and reporting
structure alongside its strategic initiatives. The key segments are
now Global Managed Services, Global Specialist Staffing, Regional
Specialist Staffing and Healthcare.
-- The new structure supports an increasingly integrated
business model which will drive increased collaboration and reduce
duplication and costs across the Group.
-- Group revenues increased by 1.4% at constant exchange rates
(2.5% increase at actual exchange rates) and gross profit increased
marginally by 0.1% at constant exchange rates (1.7% increase at
actual exchange rates). The Group has delivered a solid performance
across the portfolio although challenging market conditions have
negatively impacted the retail, automotive and healthcare
sectors.
-- Adjusted EBITDA is up GBP3m compared to the same period last
year. The impact of two previously reported customer losses in the
US together with the implementation costs of significant customer
wins in the UK and US has led to a GBP2m decrease in adjusted
EBITDA which is offset by a GBP5.0m improvement due to the adoption
of IFRS 16.
-- Operating profit was GBP9.4m (2018: GBP15.3m). In addition to
the adjusted EBITDA shortfall this was impacted by the change made
in December 2018 to the estimated economic useful life used for
Brand Value amortisation (GBP3.2m) and an increase in separately
disclosed items from GBP0.4m to GBP1.5m.
-- Net debt was reduced by 5.2% from GBP79.1 million at H1 2018
to GBP75.0 million at H1 2019 excluding the impact of IFRS 16. The
effect of IFRS 16 is the recognition of additional Net Debt (lease
liabilities) of GBP24.9m. With this included, reported net debt
increases year-on-year by GBP20.8m to GBP99.9m.
-- On the 7(th) March Carlisle Support Services Group was
de-merged from the Group, allowing Impellam to further focus on its
portfolio of Managed Services and Specialist Staffing
businesses.
-- On the 8(th) July Impellam acquired Flexy Corporation
Limited, a leading flexible staffing platform based in London which
will enable the Group to offer new solutions, more choice, and
better, technology-led experiences for customers and candidates
alike.
Julia Robertson, Chief Executive Officer, commented:
"Despite continuing challenging trading conditions in the UK and
the final exit of customer losses notified in 2018 I am pleased to
report revenue growth of 1.4% (at constant exchange rates) and
overall gross profit in line with last year (at constant exchange
rates).
Encouraged by this stable revenue and gross profit performance
we are focused on transforming the Group and creating a business
model which further improves collaboration (Group Supply(1) and
cross sell) and reduces costs arising from duplication (IT systems,
support services, back offices and recruitment process).
Our new segmental structure will allow increased integration of
the brands under collaborative management. Global Managed Services
includes our core managed service providers Guidant Global and
Comensura which operate in the UK, US, Europe and Australasia.
Global Specialist Staffing includes the technology brands (Lorien,
OneZeero and Scom) and life sciences brands (SRG and SRG Woolf)
which operate across the UK, US and Europe. Regional Specialist
Staffing includes the brands that are industry specialists in their
own territory - Blue Arrow, Tate, Carbon60, Celsian, Career
Teachers and Chadwick Nott in the UK and Bartech Staffing and
Corestaff in the US. The Healthcare segment is Medacs Global Group
which operates in the UK, Europe and Australasia.
The leaders of our three core segments, Global Managed Services,
Global Specialist Staffing and Regional Specialist Staffing are
working closely together in pursuit of our strategic goals and
early signs for future quality of earnings improvements and cost
reductions are promising.
The new structure of the business is accelerating collaboration
between the brands and continued focus on Group Supply(1) is
delivering benefits to both the Managed Services and Specialist
Staffing businesses. An increased focus on Group Supply(1) in the
US means that this has grown by 0.5ppts to 8.0% (excluding the loss
of 2 clients during 2018). In the UK Group Supply(1) has increased
by 0.3ppts.
Our Global Managed Services businesses are winning a record
number of new customers. Notwithstanding success in acquiring new
customers, Guidant Global gross profit is down 6.9% (at constant
exchange rates) due to the impact of previously reported lost
customers and additional costs in implementation of new customers.
Comensura delivered a strong H1 performance in the UK, and
Australasia gross profit grew by 24.1%. Younifi, our new innovative
platform solution in the social care market, has passed an
important milestone and is in the midst of implementing its first
customer.
Our Global Specialist Staffing businesses have seen growth in
the Life Sciences market (SRG and SRG Woolf), particularly in the
UK. Although the Technology businesses (Lorien, OneZeero and Scom)
have delivered in line with prior year we are seeing a slowdown in
the UK, offset with strong performance in the US. Whilst contract
hiring remains stable there are early signs of an increase in
permanent hiring, possibly driven by concerns around IR35 or the
impact of Brexit.
In our Regional Specialist businesses we continue to experience
challenges in the UK as a result of difficult market conditions,
particularly in the retail and automotive sectors, as well as the
ongoing uncertainty of Brexit. However we are seeing gross profit
growth in Education and Legal in the UK and Engineering in both the
UK and US and we continue to drive Group Supply(1) , particularly
in the US businesses. With an increased focus on eradicating
duplication and scrupulous cost management we have identified a
number of savings for H2 to improve gross profit conversion to
offset the impact of challenging markets.
Our Healthcare business (Medacs Global Group, MGG) is growing in
Ireland and Australasia and we are also winning new business in the
competitive Healthcare managed services market in the UK. We
continue to work with the NHS to develop and deliver a sustainable
temporary workforce for the NHS. However ongoing cost constraints
in the public sector, the impact of IR35 and a shortage of
candidates are still affecting performance and putting pressure on
our conversion of gross margin to EBITDA.
We also continue our strategic IT investment in Ignite, our
recruiters' operating system, which is now live in 38 Blue Arrow
branches and on site locations having completed a further 18 new
implementations in the first half of 2019. We will complete the
remaining branches and on site locations by the end of 2019.
On the 8(th) July Impellam acquired Flexy Corporation Limited, a
leading flexible staffing platform. Flexy provides an innovative,
data-driven analysis platform to provide insights and
consumer-grade digital experiences. The efficiency gained through
the utilisation of technology combined with Impellam's deep
staffing experience will augment our portfolio and service offering
to customers and candidates."
Global Managed Services - UK, Europe, US and Australasia
Gross profit increased by 1.9% to GBP37.0m (2018: GBP36.3m) at
actual exchange rates but was 0.8% down at constant exchange rates.
Adjusted EBITDA (excluding IFRS 16 adjustment) decreased 13.5%
(16.4% at constant exchange rates) with conversion of gross profit
to adjusted EBITDA of 24.3% compared to 28.7% in the same period
last year. Gross profit has increased in the UK although the
changing mix of clients continues to impact conversion of gross
profit to adjusted EBITDA. In H1, Guidant Global secured 5
significant new customers and Comensura secured 8 new customers. In
addition 10 new customer programmes were implemented and went live
in Guidant Global (including The Office Groups, Immunomedics,
Amway, Johnson Matthey, Crown Castle and Mary Kay).
Global Specialist Staffing - UK, Europe and US
Gross profit increased by 2.6% to GBP27.4m (2018: GBP26.7m) at
actual exchange rates and 1.2% at constant exchange rates. Adjusted
EBITDA (excluding IFRS 16 adjustment) increased 3.8% (1.0% at
constant exchange rates) with conversion of gross profit to
adjusted EBITDA of 29.6% compared to 29.2% in the same period last
year. Lorien were confirmed as a supplier of Interim IT staff
services for the Scottish Government. Already Scotland's largest
supplier of interim IT workers, their addition to the 4 year
Interim IT Staff Services Framework allows them to provide
in-demand skills to support key Scottish public sector bodies.
Lorien were also appointed to the DPS and G-Cloud 11 frameworks as
they continue to expand their public sector practice.
Regional Specialist Staffing - UK and US
Gross profit was flat on 2018 at GBP47.1m at actual exchange
rates (1.6% decrease at constant exchange rates). Adjusted EBITDA
(excluding IFRS 16 adjustment) decreased 13.2% (14.9% at constant
exchange rates) with conversion of gross profit to adjusted EBITDA
of 7.0% compared to 8.1% in the same period last year. The
difficult market conditions particularly in retail and automotive
as well as the ongoing uncertainty of Brexit are having an impact
in this segment, with pressure on gross profit and the brand mix
contributing to the fall in conversion to adjusted EBITDA.
Healthcare - UK, Europe and Australasia
Gross profit increased by 3.4% to GBP24.0m (2018: GBP23.2m) at
actual exchange rates and 4.0% at constant exchange rates. Adjusted
EBITDA (excluding IFRS 16 adjustment) decreased 7.7% (2.5% at
constant exchange rates) with conversion of gross profit to
adjusted EBITDA of 5.0% compared to 5.6% in the same period last
year. The European and Australasia businesses are growing year on
year however the UK business continues to be impacted by cost
constraints in the public sector, IR35 and a shortage of
candidates. MGG's strategy of entering the staff bank market in the
UK is gaining momentum. Building on a successful performance in the
Department of Health and Social Care's Flexible Staff Bank Pilots,
MGG has been awarded its second Staff Bank Management Contract,
which went live in May.
Cash flow, net debt and net assets
The Group generated GBP22.4 million of cash from operations in
the first twenty-six weeks of the year (2018: GBP8.7 million). Days
Sales Outstanding, being total trade receivables divided by average
daily invoiced sales, reduced by 0.6 days from 39.5 days at the end
of FY2018 to 38.9 days at the end of H1 2019. Day-to-day control of
cash and tight control of working capital continues to be a
priority for the Group. Net debt reduced by 5.2% year on year from
GBP79.1m H1 2018 to GBP75.0m in H1 2019 excluding the impact of
IFRS 16. This was up from GBP71.7m at the end of FY2018 which
included the benefits of strong receipts prior to the year end.
IFRS 16 increases net debt by GBP24.9m to GBP99.9m in H1 2019.
The Group has outstanding letters of credit drawn against its US
borrowing facilities amounting to GBP3.6 million (4 January 2019:
GBP5.1 million).
At 5 July 2019, the Group had net assets of GBP261.0 million (4
January 2019: GBP269.4 million).
Dividend and dividend policy
The Board has not declared an interim dividend. Instead, the
Group will undertake a share buyback programme commencing in Q3
2019, whereby it will return cash to shareholders though the
purchase of ordinary shares in the Company, up to an aggregate
market value of GBP12 million over a period of 12 months. The Board
is of the opinion that, as the buyback programme delivers
improvements to underlying EPS, it remains in the best interests of
shareholders. The proposed quantum of the buyback, being GBP12
million, reflects the value that the Board would otherwise have
intended to return to shareholders through dividends over the same
period.
Trading outlook
We do not anticipate an improvement in external market
conditions in H2 but we expect an improvement in conversion of
gross profit to adjusted EBITDA due to a reduced cost base driven
by our transformation to an integrated business model and the
implementation and go-live of known managed services wins.
1. Group Supply is the value of the Spend Under Management
supplied by other areas of the Group.
Financial results for the twenty-six weeks to 5 July 2019
The table below sets out the results for the Group by segment
for the first half of 2019.
Unaudited Revenue Gross profit Adjusted EBITDA(3)
Like-for-like Like-for-like Like-for-like
GBP'million 2019 2018 change(1) 2019 2018 change(1) 2019 2018 change(1)
Global Managed
Services 372.0 350.3 5.0 37.0 36.3 (0.8) 9.0 10.4 (16.4)
Gross profit
% 9.9% 10.4%
Global
Specialist
Staffing 336.0 339.1 (1.5) 27.4 26.7 1.2 8.1 7.8 1.0
Gross profit
% 8.2% 7.9%
Regional
Specialist
Staffing 326.5 330.6 (3.1) 47.1 47.1 (1.6) 3.3 3.8 (14.9)
Gross profit
% 14.4% 14.2%
Healthcare 122.1 120.7 1.8 24.0 23.2 4.0 1.2 1.3 (2.5)
Gross profit
% 19.7% 19.2%
Inter-segment
revenues (21.6) (33.0) - - - -
------ ------ --------------
Total 1,135.0 1,107.7 135.5 133.3 21.6 23.3
--------- -------- ------ ------ ------ ------ --------------
Corporate costs (1.5) (1.2)
IFRS 16 adjustment(2) 5.0 -
------ ------ --------------
Adjusted EBITDA before separately disclosed
items and share based payments(3) 25.1 22.1
Depreciation and
amortisation(4) (9.2) (3.9)
Loss on disposal - (0.3)
------ ------ --------------
Adjusted operating
profit(5) 15.9 17.9
Amortisation of acquired intangible
assets (5.0) (1.8)
Separately disclosed
items (1.5) (0.4)
Share-based payments - (0.4)
------ ------ --------------
Operating profit 9.4 15.3
------ ------ --------------
1. % change measured at constant exchange rates.
2. IFRS 16 adjustment is the add back of operating lease charges (see note 2).
3. Adjusted EBITDA is EBITDA before separately disclosed items and share-based payments.
4. Includes IFRS 16 amortisation (see note 2).
5. Before separately disclosed items, share-based payments and
amortisation of acquired intangibles.
Consolidated income statement
For the twenty-six weeks ended 5 July 2019
26 weeks 26 weeks
5 July 29 June
2019 2018
Notes GBPm GBPm
Unaudited Unaudited
(as restated)
Continuing operations
Revenue 2 1,135.0 1,107.7
Cost of sales (999.5) (974.4)
--------- --------------
Gross profit 2 135.5 133.3
Administrative expenses (126.1) (118.0)
--------- --------------
Operating profit 2 9.4 15.3
-------------------------------------------- ----- --------- --------------
Adjusted operating profit 15.9 17.9
Amortisation of acquired intangible assets (5.0) (1.8)
Separately disclosed items 5 (1.5) (0.4)
Share-based payment - (0.4)
--------- --------------
Operating profit 9.4 15.3
-------------------------------------------- ----- --------- --------------
Finance expense 6 (3.8) (3.2)
--------- --------------
Profit before taxation 5.6 12.1
Taxation 7 (1.4) (1.6)
--------- --------------
Profit for the period from continuing operations 4.2 10.5
--------- --------------
Profit from discontinued operations, net of
tax 0.7 0.1
--------- --------------
Profit for the period attributable to owners
of the parent Company 4.9 10.6
--------- --------------
Earnings per share for equity holders of
the parent Company
Basic 89.9 p 21.0p
Diluted 89.9 p 20.7p
----- -----
Consolidated statement of comprehensive income
For the twenty-six weeks ended 5 July 2019
26 weeks 26 weeks
5 July 29 June
2019 2018
GBPm GBPm
Unaudited Unaudited
Profit for the period 4.9 10.6
Other comprehensive income:
Currency translation differences (net of tax) 2.2 1.2
-------------------- --------------------
Total comprehensive income for the period, net
of tax, attributable to owners of the parent
Company 7.1 11.8
-------------------- --------------------
Consolidated balance sheet
As at 5 July 2019
5 July 2019 4 January 2019
GBPm GBPm
Unaudited Audited
Non-current assets
Property, plant and equipment 31.2 6.7
Goodwill 152.8 156.2
Other intangible assets 127.4 131.1
Financial assets 1.5 1.4
Deferred tax assets 15.1 15.3
----------- --------------
328.0 310.7
----------- --------------
Current assets
Trade and other receivables 604.2 569.1
Cash and cash equivalents 89.2 77.2
----------- --------------
693.4 646.3
----------- --------------
Total assets 1,021.4 957.0
----------- --------------
Current liabilities
Short-term borrowings 34.3 25.1
Trade and other payables 540.1 508.3
Taxation payable 1.9 1.7
Provisions 0.9 0.9
----------- --------------
577.2 536.0
----------- --------------
Net current assets 116.2 110.3
----------- --------------
Non-current liabilities
Long-term borrowings 154.8 123.8
Other payables 2.1 1.6
Provisions 3.3 3.4
Deferred tax liabilities 23.0 22.8
----------- --------------
183.2 151.6
----------- --------------
Total liabilities 760.4 687.6
----------- --------------
Net assets 261.0 269.4
----------- --------------
Equity
Issued share capital 0.5 0.5
Share premium account 30.1 30.1
----------- ----------------
30.6 30.6
Other reserves 126.8 124.6
Retained earnings 103.6 114.2
----------- ----------------
Total equity attributable to owners of the
parent Company 261.0 269.4
----------- ----------------
Non-controlling interest - -
----------- ----------------
Total equity 261.0 269.4
----------- ----------------
Consolidated statement of changes in equity
For the twenty-six weeks ended 5 July 2019
Total Total equity
share attributable
capital to equity
and share Other Retained owners of Non-controlling Total
premium reserves earnings the parent interest equity
Unaudited GBP m GBP m GBP m GBP m GBP m GBP
m
5 January 2019 30.6 124.6 114.2 269.4 - 269.4
----------- ---------- ---------- -------------- ---------------- --------
Profit for the period - - 4.9 4.9 - 4.9
Other comprehensive income - 2.2 - 2.2 - 2.2
----------- ---------- ---------- -------------- ---------------- --------
Total comprehensive income
in the period - 2.2 4.9 7.1 - 7.1
Transactions with owners,
recorded directly in equity
Purchase of Treasury shares - - (5.7) (5.7) - (5.7)
De-merger charge - - (8.1) (8.1) - (8.1)
Dividend - - (1.7) (1.7) - (1.7)
----------- ---------- ---------- -------------- ---------------- --------
5 July 2019 30.6 126.8 103.6 261.0 - 261.0
----------- ---------- ---------- -------------- ---------------- --------
Consolidated cash flow statement
For the twenty-six weeks ended 5 July 2019
26 weeks 26 weeks
5 July 29 June
2019 2018
GBPm GBPm
Unaudited Unaudited
(as restated)
Cash flows from operating activities
Profit before taxation 5.6 12.1
Adjustments for:
Net interest charge 3.8 3.2
Depreciation and amortisation 14.2 5.7
Loss on disposal - 0.3
Discontinued operations (0.7) 0.1
Share-based payment - 0.4
---------------------- ----------------------
22.9 21.8
(Increase) / Decrease in trade and other receivables (39.5) 67.1
Increase / (Decrease) in trade and other payables 39.1 (80.1)
Decrease in provisions (0.1) (0.1)
---------------------- ----------------------
Cash generated by operations 22.4 8.7
Taxation paid (1.6) (3.1)
---------------------- ----------------------
Net cash generated by operating activities 20.8 5.6
---------------------- ----------------------
Cash flows from investing activities
Payment of deferred consideration (0.8) (0.7)
Purchase of property, plant and equipment (5.3) (2.1)
Purchase of intangible assets (4.0) (3.0)
Cash outflow on discontinued operations (2.5) -
Net movement in other financial assets (0.1) -
---------------------- ----------------------
Net cash utilised on investing activities (12.7) (5.8)
---------------------- ----------------------
Cash flows from financing activities
Decrease / (Increase) in short-term borrowings 15.5 (14.0)
Purchase of treasury shares (5.7) (0.5)
Finance expense paid (3.8) (3.1)
Repayment of lease liabilities (2018: Capital
element of net finance lease payments) (4.3) 0.6
Inflow from new leases 3.6 -
---------------------- ----------------------
Net cash inflow / (outflow) from financing activities 5.3 (17.0)
---------------------- ----------------------
Net increase / (decrease) in cash and equivalents 13.4 (17.2)
Opening cash and cash equivalents 77.2 100.3
Foreign exchange (loss) / gain on cash and cash
equivalents (1.4) 0.5
---------------------- ----------------------
Closing cash and cash equivalents 89.2 83.6
---------------------- ----------------------
Notes to the interim financial statements
1 Basis of preparation
I. Statement of compliance
The interim financial statements presented in this financial
report have been prepared in accordance with International
Financial Reporting Standards (IFRS) and the IFRS Interpretations
Committee (IFRIC) interpretations as endorsed by the European Union
that are expected to be applicable to the consolidated financial
statements for the period ending 3 January 2020. As permitted, this
interim report has been prepared in accordance with the AIM Rules
for Companies and does not seek to comply with IAS 34 "Interim
Financial Reporting".
II. Statutory information
The financial information for the 26 weeks to 5 July 2019 does
not constitute the statutory accounts of the Group for the relevant
period within the meaning of section 434 of the Companies Act
2006.
The published annual report and accounts of Impellam Group plc
for the period ended 5 January 2019 were reported on by the
auditors without qualification, did not contain an emphasis of
matter paragraph, did not contain any statement under section 498
of the Companies Act 2006, and have been delivered to the Registrar
of Companies.
III. Accounting policies, new IFRS and interpretations
The accounting policies used in this report are with those
applied at 5 January 2019, but have also adopted the following new
IFRS.
a) IFRS 9 - Financial Instruments. As disclosed in the last
annual report the Group has had no significant changes since the
adoption of this standard.
b) IFRS 15 - Revenue from Contracts with Customers. The Group
has adjusted the level of revenue recognised on the
agency-principal basis. This will purely lead to amendments to
revenue and cost of sales with no change in gross profit (see note
4).
c) IFRS 16 - Leases. The Group has reviewed its portfolio of
leases as at 5 January 2019 and decided to account for IFRS 16 on
the modified retrospective approach using a single discount rate
for portfolio leases with similar characteristics. Advantage has
been taken of the exemption provided for low value leases. The
Group is using the methodology to set the right-of-use asset equal
to the lease liability upon adoption of IRFS 16.
No other new and/or revised IFRS and IFRIC publications that
come into force in the period have any material impact on the
accounting policies, financial position or performance of the
Group.
2 Segmental information
Twenty-six weeks ended 5 July 2019 - unaudited
Segment
Adjusted
Revenue Gross profit EBITDA
GBP m GBP m GBP m
Global Managed Services 372.0 37.0 9.0
Global Specialist Staffing 336.0 27.4 8.1
Regional Specialist Staffing 326.5 47.1 3.3
Healthcare 122.1 24.0 1.2
Inter-segment revenues (21.6) - -
-------- ------------- ----------
Operating segments 1,135.0 135.5 21.6
-------- ------------- ----------
Twenty-six weeks ended 29 June 2018 - unaudited (as
restated)
Segment
Adjusted
Revenue Gross profit EBITDA
GBP m GBP m GBP m
Global Managed Services 350.3 36.3 10.4
Global Specialist Staffing 339.1 26.7 7.8
Regional Specialist Staffing 330.6 47.1 3.8
Healthcare 120.7 23.2 1.3
Inter-segment revenues (33.0) - -
-------- ------------- ----------
Operating segments 1,107.7 133.3 23.3
-------- ------------- ----------
Unaudited 26 weeks 26 weeks
5 July 29 June
2019 2018
GBP m GBP m
Segment adjusted EBITDA 21.6 23.3
Corporate costs (1.5) (1.2)
IFRS 16 adjustment 5.0 -
--------- ---------
Adjusted EBITDA before Separately Disclosed
items and share-based payment 25.1 22.1
Amortisation and depreciation (9.2) (3.9)
Loss on disposal - (0.3)
--------- ---------
Adjusted operating profit 15.9 17.9
Amortisation of acquired intangibles (5.0) (1.8)
Separately disclosed items (1.5) (0.4)
Share-based payment - (0.4)
--------- ---------
Operating profit 9.4 15.3
Finance expense (3.8) (3.2)
Taxation charge (1.4) (1.6)
--------- ---------
Profit for the period from continuing operations 4.2 10.5
--------- ---------
The above table reconciles the adjusted Earnings Before
Interest, Tax, Depreciation and Amortisation ('EBITDA'), which also
excludes separately disclosed items and share-based payments to the
standard profit measure under International Financial Reporting
Standards (Operating Profit). This is the Alternative Profit
Measure used when discussing the performance of the Group. The
Directors believe that adjusted EBITDA is the most appropriate
approach for ascertaining the underlying trading performance and
trends as it reflects the measures used internally by senior
management for all discussions of performance, including Directors'
remuneration, and also reflects the starting profit measure used
when calculating the Group's banking covenants. All discussions
within the Group on segmental and individual brand performance
refer to adjusted EBITDA. Corporate costs represent costs
associated with being a listed company with a wide portfolio of
brands and therefore are not allocated to the segments.
Following the adoption of IFRS 16 in 2019 the Group is moving to
adjusted operating profit as its Alternative Profit Measure, to
include depreciation and amortisation of assets but excluding
amortisation of acquired intangibles, and this is included in the
above table for reference. As this transition has not been
finished, the segmental analysis has been completed with operating
lease payments included within the segment numbers so that the
year-on-year performance is comparable. An adjustment is therefore
made to remove these costs to get to Adjusted EBITDA.
Adjusted EBITDA is not defined by IFRS and therefore may not be
directly comparable with other companies' alternative profit
measures. It is not intended to be a substitute, or superior to,
IFRS measurements of profit.
Separately disclosed items are costs or income that have been
recognised in the income statement which the Directors believe, due
to their nature or size, should be disclosed separately to give a
more comparable view of the year-on-year underlying financial
performance (note 5).
Share-based payments are shown separately due to their size in
order to give a more comparable view of the year on year underlying
financial performance.
3 Discontinued operations
In March 2019 the Group de-merged Carlisle Support Services
Group Ltd and its subsidiaries ("CSS").
The CSS segment was not previously classified as held-for-sale
or as a discontinued operation. The comparative consolidated
statement of profit or loss and consolidated statement of
comprehensive income has been re-presented to show the discontinued
operation separately from continuing operations.
Subsequent to the disposal, the Group has continued to trade
with the discontinued operation. Intra-group transactions have been
fully eliminated in consolidated financial results and management
has elected not to attribute the elimination of transactions
between the continuing operations and the discontinued operation
before the disposal as the level of this is small in comparison to
the total trade of both the continuing and discontinued trade.
Results from discontinued operations
26 weeks 26 weeks
5 July 29 June
2019 2018
GBPm GBPm
Unaudited Unaudited
Revenue 9.6 25.8
Cost of sales (8.7) (23.6)
--------- ---------
Gross profit 0.9 2.2
Administrative expenses (0.2) (2.1)
--------- ---------
Profit from operating activities 0.7 0.1
Taxation - -
--------- ---------
Profit from discontinued operations 0.7 0.1
--------- ---------
Cash flows relating to discontinued operations 26 weeks 26 weeks
5 July 29 June
2019 2018
GBPm GBPm
Unaudited Unaudited
Net cash generated by operating activities 0.5 (0.3)
Net cash (outflow) from financing activities (0.1) -
---------------------- ----------------------
Net cash flows for discontinued operations 0.4 (0.3)
Effect of disposal on the financial position of the Group
5 July
2019
GBPm
Unaudited
Property, plant and equipment 0.5
Goodwill 4.8
Deferred tax assets 0.3
Trade and other receivables 9.9
Cash and cash equivalents 2.5
Trade and other payables (8.7)
Lease liabilities (0.3)
----------------------
Net assets and liabilities 9.0
4 Comparative restatement
As well as the re-statement for discontinued operations in note
3, and following the adoption of IFRS 15 - Revenue from Contracts
with Customers, the Group has completed a review of the accounting
for revenue under the Agency/Principal basis which has led to an
increase in revenue for the Group for the 26 weeks to 29 June 2018
of GBP23.9m with a corresponding decrease in cost of sales.
5 Separately disclosed items - unaudited
26 weeks 26 weeks
5 July 29 June
2019 2018
GBP m GBP m
Acquisition costs (1) (0.4) 0.4
Group de-merger (2) 0.8 -
Legal costs (3) 1.1 -
-------- --------
1.5 0.4
-------- --------
(1) Acquisition costs relate to contingent consideration in
respect of Global Medics in 2019 and 2018. 2018 costs also include
a provision for bonuses following synergies arising from the
acquisition of Bartech in 2015. These costs are one-off in nature
and have been disclosed in order not to distort the underlying
trading performance of the business.
(2) The Group de-merged Carlisle Support Services Group in 2019,
incurring costs of GBP0.8m. These costs are one-off in nature and
have been disclosed in order not to distort the underlying trading
performance of the business.
(3) In 2019 the Group negotiated an amend and extend to its
Revolving credit facilities ("RCF") arrangement before the 2020
expiry date, the outstanding fees for the original RCF have been
taken as a cost in 2019. In addition the Group had an ongoing
litigation matter for which a provision was made in 2018, in 2019 a
further GBP0.1m of legal costs was incurred. These are disclosed
separately due to their one-off nature and significance.
6 Finance expense - unaudited
26 weeks 26 weeks
5 July 29 June
2019 2018
Finance expense GBP m GBP m
Revolving credit facilities 3.2 3.1
Interest on lease liabilities 0.6 -
Other interest expense - 0.1
--------- ---------
Income statement 3.8 3.2
--------- ---------
7 Taxation - unaudited
Income tax expense is recognised based on management's best
estimate of the effective annual income tax rate expected for the
full financial year. Included in the current period total is a
charge of GBP0.7m in relation to corrections to the provision of
the prior period.
8 Earnings per share - unaudited
Basic earnings per share amounts are calculated by dividing the
profit for the period attributable to the owners of the Company by
the weighted average number of Ordinary shares outstanding during
the period.
Diluted earnings per share amounts are calculated on the same
basis but after adjusting the denominator for the effects of
dilutive options. The only potentially dilutive shares arise from
the share options issued by the Group under its share-based
compensation plans. There were no options outstanding at 5 July
2019 (29 June 2018: 850,000).
Excluding the 19,841 shares owned by The Corporate Services
Group Ltd Employee Share Trust, the weighted average number of
shares in 2019 is 49,160,900 (2018: 50,270,957) and the fully
diluted average number of shares is 49,180,741 (2018:
51,140,798).
26 weeks 26 weeks
5 July 29 June
2019 2018
GBPm
GBPm (as restated)
Continuing profit for the period 4.2 10.5
Discontinued profit for the period 0.7 0.1
---------- --------------
Total profit for the period 4.9 10.6
Separately disclosed items (net of tax) 1.3 0.8
Acquired intangibles amortisation (net of tax) 4.0 1.5
---------- --------------
Total adjusted profit 10.2 12.9
---------- --------------
Continuing adjusted profit 9.5 12.8
Discontinued adjusted profit 0.7 0.1
---------- --------------
Weighted average number of shares 49,160,900 50,270,957
26 weeks 26 weeks
5 July 29 June
2019 2018
Basic EPS Pence
Pence (as restated)
Continuing unadjusted basic earnings per share 8.5 20.9
Discontinued unadjusted basic earnings per share 1.4 0.1
---------- --------------
Total unadjusted basic earnings per share 9.9 21.0
Separately disclosed items (net of tax) 2.6 1.5
Acquired intangible asset amortisation (net
of tax) 8.1 2.9
---------- --------------
Total adjusted basic earnings per share 20.6 25.4
---------- --------------
Continuing adjusted basic earnings per share 19.2 25.3
Discontinued unadjusted basic earnings per share 1.4 0.1
---------- --------------
Fully diluted weighted average number of shares 49,180,741 51,140,798
26 weeks
26 weeks 29 June
5 July 2018
2019 (as restated)
Diluted EPS Pence Pence
Continuing unadjusted diluted earnings per share 8.5 20.6
Discontinued unadjusted diluted earnings per
share 1.4 0.1
---------- --------------
Total unadjusted diluted earnings per share 9.9 20.7
Separately disclosed items (net of tax) 2.6 1.5
Acquired intangible asset amortisation (net
of tax) 8.1 2.8
---------- --------------
Total adjusted diluted earnings per share 20.6 25.0
---------- --------------
Continuing adjusted diluted earnings per share 19.2 24.9
Discontinued unadjusted diluted earnings per
share 1.4 0.1
---------- --------------
9 Additional cash flow information - unaudited
Change
5 January Cash Interest Interest in short Foreign 5 July
Unaudited 2019 flow paid expense term borrowings exchange 2019
GBP m GBP m GBP m GBP m GBP m GBP m GBP m
Cash and short-term
deposits 77.2 (2.1) - - 15.5 (1.4) 89.2
Revolving credit (148.5) - (3.2) 3.2 (15.5) 0.1 (163.9)
Hire purchase (0.4) 0.1 - - - - (0.3)
Lease liabilities - 4.9 (0.6) 0.6 (29.7) (0.1) (24.9)
--------- ----- -------- -------- ---------------- --------- -------
Net debt (71.7) 2.9 (3.8) 3.8 (29.7) (1.4) (99.9)
--------- ----- -------- -------- ---------------- --------- -------
10 Leases
Property, plant and equipment comprise owned and leased assets,
including right-of-use assets which have been created under IFRS 16
- Leases. Information about these assets and the related lease
liabilities are presented below.
Total property, plant and equipment 5 July 5 January
2019 2019
GBP m GBP m
Property, plant and equipment (owned) 6.6 6.7
Right of use assets 24.6 -
------ ---------
31.2 6.7
------ ---------
Right of use assets Property Vehicles Total
GBP m GBP m GBP m
Balance at 5 January 2019 - - -
Additions in the period 28.1 1.4 29.5
Depreciation charge in
the period (4.2) (0.3) (4.5)
Disposals (net) - (0.3) (0.3)
Impairment (0.1) - (0.1)
Foreign exchange (net) 0.1 - 0.1
-------- -------- -----
Balance at 5 July 2019 23.9 0.8 24.7
-------- -------- -----
Lease liability maturity analysis
Discounted contractual cash flows Property Vehicles Total
GBP m GBP m GBP m
Less than one year 8.9 0.5 9.4
More than one year but less than five
years 12.4 0.3 12.7
More than five years 2.8 - 2.8
24.1 0.8 24.9
-------- -------- -----
Enquiries: For further information please contact:
Impellam Group plc
Julia Robertson, Group Chief Executive Tel: 01582 692658
Cenkos Securities plc (NOMAD and Corporate Broker to Impellam)
Nicholas Wells Callum Davidson Tel: 020 7397 8900
This announcement contains inside information for the purposes
of Article 7 of EU Regulation 596/2014
Note to Editors:
Impellam is the second largest(1) staffing company in the UK and
sixth largest(2) Managed Services provider worldwide. Our vision is
to be the world's most trusted staffing company - trusted by our
people, our customers and our investors in equal measure.
We provide Managed Services and Specialist Staffing solutions
across the UK, Europe, US, the Middle East and Australasia. We have
over 3,200 Impellam people throughout our network of 17
market-leading brands across 165 worldwide locations.
Ultimately, Impellam Group's mission is to provide fulfilment
and a sense of purpose to our people and to help customers build
better businesses in a changing world.
For more information about Impellam Group please visit:
www.impellam.com
1 By revenue (2017 published numbers)
2 By SUM (confirmed by Staffing Industry Analysts). Spend Under
Management (SUM) is the total amount of client expenditure which
our Managed Services brands manage on behalf of their clients. This
equates to revenue earned where Impellam acts as principal plus
gross billings to customers where Impellam acts as agent (2017
published numbers). Management use this measure as it reflects the
total value of the client spend to the Group and not just the
revenue generated
-END-
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
IR LFFSLDLIAFIA
(END) Dow Jones Newswires
July 30, 2019 02:01 ET (06:01 GMT)
Impellam (LSE:IPEL)
Historical Stock Chart
From Apr 2024 to May 2024
Impellam (LSE:IPEL)
Historical Stock Chart
From May 2023 to May 2024